Michael Sistenich

DWS Ltd. engages in the provision of consultancy services in the information technology industry. It offers technology design and delivery; program and project management; experience design, CX and UX; automation and intelligence; strategy and business improvement; data and analytics; government services; digital transformation; and cloud services. The company was founded by Daniel Wallis Benedict in 1991 and is headquartered in Melbourne, Australia.

Meditor Capital Management Ltd. (MCML) is an investment management firm headquartered in Berkshire, UK. The firm was founded in 1998 and is a subsidiary of Meditor Group Ltd. in Bermuda. MCML exclusively manages the Meditor Group assets through a highly concentrated portfolio of long-term equity positions.

Bell Potter Securities Ltd. (Bell Potter) is the stockbroking subsidiary of Bell Financial Group Ltd. (ASX: BFG) in Australia. The firm was created in 2001 when Bell Financial Group acquired Johnson Taylor Potter and merged them with the Bell Securities share broking business. Bell Potter is headquartered in Melbourne and offer stockbroking, portfolio management and administration, cash management, margin lending, superannuation and financial planning to private, corporate and institutional clients. Their institutional broking services are supported by a dedicated research team, a team of specialists in equity capital markets providing small, mid and large-cap corporate clients with advice, and a team of advisers across a network of offices in Australia, as well as in London and Hong Kong.

DWS Investments Australia Ltd. (DIAL) is an asset management firm headquartered in Sydney, Australia. Formerly known as Deutsche Investments Australia Ltd., the firm is a subsidiary of DWS Group GmbH & Co. KGaA, which is ultimately held by Deutsche Bank AG (ETR: DBK) in Germany. DIAL primarily performs advisory services for the US SEC-registered investment adviser RREEF America LLC (RREEF). The firm also separately manages special purpose vehicles holding equity interests in real estate assets via management investment trust structures on behalf of non-US investors.

Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA.

JumpStart Fertility, Inc. operates in the health care industry. The company is headquartered in Chestnut Hill, MA.